Myriad Genetics (MYGN) Institutional Ownership $3.55 -0.10 (-2.74%) Closing price 04:00 PM EasternExtended Trading$3.57 +0.02 (+0.56%) As of 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Myriad Genetics (NASDAQ:MYGN)CurrentInstitutional OwnershipPercentage99.02%Number ofInstitutional Buyers(last 12 months)133TotalInstitutional Inflows(last 12 months)$714.10MNumber ofInstitutional Sellers(last 12 months)72TotalInstitutional Outflows(last 12 months)$94.33M Get MYGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Myriad Genetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data MYGN Institutional Buying and Selling by Quarter Myriad Genetics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026 Bank of America Corp DE523,020$2.35M0.0%-39.7%0.554% 5/18/2026 Amundi27,976$126K0.0%+79.2%0.030% 5/16/2026 Quantinno Capital Management LP90,622$408K0.0%+26.8%0.096% 5/16/2026 Orbimed Advisors LLC125,000,000$562.50M10.3%N/A132.345% 5/15/2026 Weiss Asset Management LP174,844$787K0.0%N/A0.185% 5/14/2026 Renaissance Technologies LLC454,374$2.05M0.0%+19.8%0.481% 5/14/2026 Public Employees Retirement System of Ohio132,383$596K0.0%-3.7%0.140% 5/14/2026 Arrowstreet Capital Limited Partnership204,608$921K0.0%N/A0.217% 5/14/2026 Sei Investments Co.45,039$203K0.0%N/A0.048% 5/14/2026 State of Wyoming62,664$282K0.0%+134.3%0.066% Get the Latest News and Ratings for MYGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Myriad Genetics and its competitors with MarketBeat's FREE daily newsletter. 5/7/2026 Dimensional Fund Advisors LP739,051$3.33M0.0%-42.6%0.783% 5/5/2026 Bank of New York Mellon Corp334,513$1.51M0.0%-42.5%0.354% 4/30/2026 Hsbc Holdings PLC36,331$162K0.0%N/A0.038% 4/27/2026 Y Intercept Hong Kong Ltd654,224$2.94M0.1%+83.3%0.693% 4/23/2026 Inspire Investing LLC115,726$521K0.0%+28.2%0.123% 4/20/2026 OP Asset Management Ltd148,929$670K0.0%N/A0.158% 4/20/2026 Assenagon Asset Management S.A.1,446,961$6.51M0.0%+23.9%1.532% 4/16/2026 SG Americas Securities LLC51,865$233K0.0%+30.3%0.055% 2/19/2026 Invesco Ltd.507,180$3.12M0.0%+2.4%0.544% 2/18/2026 Mercer Global Advisors Inc. ADV26,886$165K0.0%+62.7%0.029% 2/18/2026 State of Tennessee Department of Treasury36,538$205K0.0%-7.8%0.039% 2/18/2026 Vestal Point Capital LP1,223,000$7.52M0.3%+103.8%1.312% 2/18/2026 Tudor Investment Corp ET AL44,820$276K0.0%N/A0.048% 2/18/2026 Oxford Asset Management LLP23,205$143K0.1%N/A0.025% 2/18/2026 Millennium Management LLC6,700,158$41.21M0.0%+41.1%7.188% 2/18/2026 Man Group plc81,959$504K0.0%N/A0.088% 2/18/2026 Inspire Investing LLC90,271$555K0.0%+13.3%0.097% 2/18/2026 Engineers Gate Manager LP64,542$397K0.0%-35.0%0.069% 2/18/2026 Balyasny Asset Management L.P.16,155$99K0.0%-88.9%0.017% 2/18/2026 Boothbay Fund Management LLC14,163$87K0.0%N/A0.015% 2/17/2026 Schonfeld Strategic Advisors LLC95,035$584K0.0%+71.4%0.102% 2/17/2026 AQR Capital Management LLC1,870,385$11.50M0.0%+17.1%2.007% 2/17/2026 EFG International AG20,983$129K0.0%N/A0.023% 2/17/2026 Jain Global LLC188,958$1.16M0.0%+143.9%0.203% 2/17/2026 Trexquant Investment LP542,495$3.34M0.0%+35.9%0.582% 2/17/2026 Jump Financial LLC168,597$1.04M0.0%+4.3%0.181% 2/17/2026 Price T Rowe Associates Inc. MD74,542$459K0.0%+23.7%0.080% 2/17/2026 California State Teachers Retirement System89,914$553K0.0%-13.3%0.096% 2/17/2026 Russell Investments Group Ltd.167,060$1.03M0.0%-3.5%0.179% 2/17/2026 State of Wisconsin Investment Board287,617$1.77M0.0%-3.8%0.309% Your book is inside (Ad)The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.Download your copy now.2/17/2026 Captrust Financial Advisors18,044$111K0.0%+26.5%0.019% 2/17/2026 ExodusPoint Capital Management LP313,370$1.93M0.0%+1,354.8%0.336% 2/17/2026 Royal Bank of Canada4,993$31K0.0%+129.6%0.005% 2/17/2026 Graham Capital Management L.P.30,097$185K0.0%N/A0.032% 2/16/2026 Squarepoint Ops LLC343,743$2.11M0.0%+190.6%0.369% 2/16/2026 Mariner LLC48,166$296K0.0%+68.2%0.052% 2/16/2026 Entropy Technologies LP14,300$88K0.0%N/A0.015% 2/16/2026 Barclays PLC301,788$1.86M0.0%+4.4%0.324% 2/13/2026 Marshall Wace LLP22,302$137K0.0%-53.2%0.024% 2/13/2026 The Manufacturers Life Insurance Company 27,495$169K0.0%-10.6%0.029% 2/13/2026 CANADA LIFE ASSURANCE Co80,201$493K0.0%-7.4%0.086% 2/13/2026 Inspire Advisors LLC26,210$161K0.0%-21.3%0.028% 2/13/2026 Walleye Capital LLC677,176$4.17M0.0%+66.8%0.727% 2/13/2026 Quarry LP4,365$27K0.0%+155.6%0.005% 2/13/2026 Virtus Advisers LLC20,000$123K0.1%N/A0.021% 2/13/2026 Jacobs Levy Equity Management Inc.2,270,378$13.96M0.1%-7.1%2.436% 2/13/2026 Public Sector Pension Investment Board322,415$1.98M0.0%-11.2%0.346% 2/13/2026 Rafferty Asset Management LLC149,229$918K0.0%+32.3%0.160% 2/13/2026 Headlands Technologies LLC86,792$534K0.0%+13.6%0.093% 2/13/2026 Charles Schwab Investment Management Inc.1,753,711$10.79M0.0%+4.5%1.881% 2/13/2026 State Street Corp5,966,567$36.69M0.0%+19.9%6.401% 2/13/2026 Ieq Capital LLC228,005$1.40M0.0%+41.1%0.245% 2/13/2026 Martingale Asset Management L P128,910$793K0.0%+74.1%0.138% 2/13/2026 Dynamic Technology Lab Private Ltd15,883$98K0.0%-60.7%0.017% 2/13/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC224,133$1.38M0.0%+11.6%0.240% 2/13/2026 Wells Fargo & Company MN437,034$2.69M0.0%-14.0%0.469% 2/12/2026 Jane Street Group LLC54,417$335K0.0%-75.7%0.058% 2/12/2026 HRT Financial LP468,868$2.88M0.0%-40.7%0.503% 2/12/2026 MetLife Investment Management LLC42,935$264K0.0%-19.4%0.046% 2/12/2026 Renaissance Technologies LLC379,374$2.33M0.0%+1,650.4%0.407% 2/12/2026 Dimensional Fund Advisors LP1,287,447$7.92M0.0%-24.1%1.381% 2/12/2026 Federated Hermes Inc.1,310,591$8.06M0.0%+16.0%1.406% 2/12/2026 Ensign Peak Advisors Inc7,356$45K0.0%-65.5%0.008% 2/12/2026 Swiss National Bank183,400$1.13M0.0%+4.0%0.197% 2/12/2026 Nuveen LLC1,190,566$7.32M0.0%+64.2%1.277% 2/11/2026 Deutsche Bank AG123,183$758K0.0%-69.2%0.132% 2/11/2026 Cerity Partners LLC86,475$532K0.0%+8.7%0.093% 2/11/2026 Franklin Resources Inc.103,374$636K0.0%+2.7%0.111% 2/11/2026 Los Angeles Capital Management LLC97,419$599K0.0%+19.7%0.105% 2/11/2026 WINTON GROUP Ltd13,500$83K0.0%N/A0.014% 2/11/2026 State of Wyoming26,742$164K0.0%-26.1%0.029% 2/10/2026 Goldman Sachs Group Inc.2,160,282$13.29M0.0%+0.4%2.318% 2/10/2026 AXQ Capital LP15,691$96K0.0%+37.1%0.017% 2/10/2026 Impact Partnership Wealth LLC16,184$100K0.0%+60.1%0.017% 2/10/2026 Intech Investment Management LLC228,779$1.41M0.0%+543.3%0.245% 2/9/2026 Geode Capital Management LLC2,231,292$13.73M0.0%+0.3%2.394% 2/9/2026 Royce & Associates LP605,000$3.72M0.0%-9.7%0.649% 2/9/2026 Fisher Asset Management LLC1,207,019$7.42M0.0%-5.6%1.295% 2/6/2026 EverSource Wealth Advisors LLC10,469$64K0.0%+139.5%0.011% 2/6/2026 GSA Capital Partners LLP187,819$1.16M0.1%N/A0.202% ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.See the 5 stocks to avoid2/5/2026 Abacus Wealth Partners LLC13,430$83K0.0%N/A0.014% 1/29/2026Comerica Bank23,922$147K0.0%-17.4%0.026% 1/29/2026 Inscription Capital LLC23,372$144K0.0%N/A0.025% 1/29/2026 UBS Group AG639,691$3.93M0.0%+29.8%0.686% 1/29/2026 Teachers Retirement System of The State of Kentucky22,848$141K0.0%-10.6%0.025% 1/29/2026Vanguard Group Inc.8,225,371$50.59M0.0%+4.3%8.825% 1/26/2026 CWM LLC71,774$441K0.0%+13.3%0.077% 1/22/2026 Massachusetts Financial Services Co. MA117,436$722K0.0%N/A0.126% 1/21/2026 Yousif Capital Management LLC25,523$145K0.0%-12.0%0.027% 1/16/2026 Aberdeen Group plc885,801$5.45M0.0%+38.6%0.950% MYGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MYGN shares? During the previous two years, 243 institutional investors and hedge funds held shares of Myriad Genetics. The most heavily invested institutionals were Orbimed Advisors LLC ($562.50M), Loomis Sayles & Co. L P ($59.97M), Vanguard Group Inc. ($50.59M), Millennium Management LLC ($41.21M), Wellington Management Group LLP ($40.73M), Artisan Partners Limited Partnership ($37.93M), and State Street Corp ($36.69M).Learn more on Myriad Genetics' institutional investors. What percentage of Myriad Genetics' stock is owned by institutional investors? 99.02% of Myriad Genetics' stock is owned by institutional investors. Learn more on MYGN's institutional investor holdings. Which institutional investors have been buying Myriad Genetics' stock? Of the 211 institutional investors that purchased Myriad Genetics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Orbimed Advisors LLC ($125M), Millennium Management LLC ($1.95M), Nuveen LLC ($1.64M), Assenagon Asset Management S.A. ($1.55M), Jacobs Levy Equity Management Inc. ($1.49M), Connor Clark & Lunn Investment Management Ltd. ($1.37M), and State Street Corp ($1.35M). How much institutional buying is happening at Myriad Genetics? Institutional investors have bought a total of 150,066,441 shares in the last 24 months. This purchase volume represents approximately $714.10M in transactions. Which of Myriad Genetics' major shareholders have been selling company stock? Of the 72 institutional investors that sold Myriad Genetics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Disciplined Growth Investors Inc. MN ($3.98M), Bank of America Corp DE ($2.56M), Vanguard Group Inc. ($1.37M), Dimensional Fund Advisors LP ($1.33M), Qube Research & Technologies Ltd ($865.08K), Anson Funds Management LP ($841.94K), and Invesco Ltd. ($427.47K). How much institutional selling is happening at Myriad Genetics? Institutional investors have sold a total of 15,775,281 shares in the last 24 months. This volume of shares sold represents approximately $94.33M in transactions. Related Companies ZBIO Major Shareholders MNKD Major Shareholders GERN Major Shareholders LXRX Major Shareholders OPK Major Shareholders IRWD Major Shareholders CBIO Major Shareholders XOMA Major Shareholders EBS Major Shareholders RIGL Major Shareholders This page (NASDAQ:MYGN) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myriad Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Myriad Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
